Format

Send to

Choose Destination
See comment in PubMed Commons below
Cardiol Young. 2014 Aug;24(4):623-31. doi: 10.1017/S1047951113000851. Epub 2013 Jul 11.

Glial fibrillary acidic protein in children with congenital heart disease undergoing cardiopulmonary bypass.

Author information

  • 11Department of Anesthesiology and Critical Care Medicine,Johns Hopkins School of Medicine,Baltimore,Maryland,United States of America.
  • 22Departments of Pediatrics and Biostatistics,Johns Hopkins School of Medicine and Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland,United States of America.
  • 33Department of Anesthesiology and Critical Care Medicine,Texas Children's Hospital and Baylor College of Medicine,Houston,Texas,United States of America.
  • 44Department of Cardiac Surgery,Johns Hopkins School of Medicine,Baltimore,Maryland,United States of America.
  • 55Department of Pediatrics,Johns Hopkins School of Medicine,Baltimore,Maryland,United States of America.

Abstract

OBJECTIVE:

To determine whether blood levels of the brain-specific biomarker glial fibrillary acidic protein rise during cardiopulmonary bypass for repair of congenital heart disease.

METHODS:

This is a prospective observational pilot study to characterise the blood levels of glial fibrillary acidic protein during bypass. Children <21 years of age undergoing bypass for congenital heart disease at Johns Hopkins Hospital and Texas Children's Hospital were enrolled. Blood samples were collected during four phases: pre-bypass, cooling, re-warming, and post-bypass.

RESULTS:

A total of 85 patients were enrolled between October, 2010 and May, 2011. The median age was 0.73 years (range 0.01-17). The median weight was 7.14 kilograms (range 2.2-86.5). Single ventricle anatomy was present in 18 patients (22%). Median glial fibrillary acidic protein values by phase were: pre-bypass: 0 ng/ml (range 0-0.35); cooling: 0.039 (0-0.68); re-warming: 0.165 (0-2.29); and post-bypass: 0.112 (0-0.97). There were significant elevations from pre-bypass to all subsequent stages, with the greatest increase during re-warming (p = 0.0001). Maximal levels were significantly related to younger age (p = 0.03), bypass time (p = 0.03), cross-clamp time (p = 0.047), and temperature nadir (0.04). Peak levels did not vary significantly in those with single ventricle anatomy versus two ventricle repairs.

CONCLUSION:

There are significant increases in glial fibrillary acidic protein levels in children undergoing cardiopulmonary bypass for repair of congenital heart disease. The highest values were seen during the re-warming phase. Elevations are significantly associated with younger age, bypass and cross-clamp times, and temperature nadir. Owing to the fact that glial fibrillary acidic protein is the most brain-specific biomarker identified to date, it may act as a rapid diagnostic marker of brain injury during cardiac surgery.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cambridge University Press
    Loading ...
    Write to the Help Desk